Literature DB >> 10473514

Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.

J L Lopez-Ribot1, R K McAtee, W R Kirkpatrick, R La Valle, T F Patterson.   

Abstract

Three serial isolates of Candida albicans were obtained by direct swab or by oral saline rinses from each of five human immunodeficiency virus-infected patients with recurrent oropharyngeal candidiasis. Genotyping techniques confirmed the presence of a persistent strain in multiple episodes from the same patient, which was different from the strains isolated from other patients. Fluconazole susceptibility was determined by both an agar dilution method and the National Committee for Clinical Laboratory Standards macrobroth procedure. In four of these patients the strains developed fluconazole resistance, and in one patient the strain remained susceptible. The different isolates were propagated as yeast cells on a synthetic medium, and their cell wall proteinaceous components were extracted by treatment with beta-mercaptoethanol. Protein and mannoprotein components present in the extracts were analyzed by electrophoresis, immunoblotting, and lectin-blotting techniques. The analysis showed a similar composition, with only minor qualitative and quantitative differences in the polypeptidic and antigenic patterns associated with the cell wall extracts from serial isolates from the same patient, as well as those from different strains isolated from different patients. Use of monospecific antibodies generated against two immunodominant antigens during candidiasis (enolase and the 58-kDa fibrinogen-binding mannoprotein) demonstrated their expression in all isolates tested. Overall, the antigenic makeup of C. albicans strains remained constant during the course of infection and was not affected by development of fluconazole resistance. In contrast to previous reports, the low degree of antigenic variability observed in this study may be due to the fact that the isolates were obtained from a highly homogeneous population of patients and to the uniformity in techniques used for the isolation, storage, and culture of the different strains, as well as extraction methodologies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473514      PMCID: PMC95751          DOI: 10.1128/CDLI.6.5.665-670.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  48 in total

Review 1.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

2.  Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics.

Authors:  L Angiolella; M Facchin; A Stringaro; B Maras; N Simonetti; A Cassone
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

3.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

Authors:  R S Klein; C A Harris; C B Small; B Moll; M Lesser; G H Friedland
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

4.  Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.

Authors:  T F Patterson; S G Revankar; W R Kirkpatrick; O Dib; A W Fothergill; S W Redding; D A Sutton; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

5.  Evidence for presence in the cell wall of Candida albicans of a protein related to the hsp70 family.

Authors:  J L López-Ribot; H M Alloush; B J Masten; W L Chaffin
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  Expression of the fibrinogen binding mannoprotein and the laminin receptor of Candida albicans in vitro and in infected tissues.

Authors:  J L López-Ribot; C Monteagudo; P Sepúlveda; M Casanova; J P Martínez; W L Chaffin
Journal:  FEMS Microbiol Lett       Date:  1996-08-15       Impact factor: 2.742

7.  Common and form-specific cell wall antigens of Candida albicans as released by chemical and enzymatic treatments.

Authors:  J L López-Ribot; M Casanova; M L Gil; J P Martinez
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

8.  An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans.

Authors:  K L Lee; H R Buckley; C C Campbell
Journal:  Sabouraudia       Date:  1975-07

Review 9.  Antigenic variability of Candida albicans.

Authors:  D Poulain; V Hopwood; A Vernes
Journal:  Crit Rev Microbiol       Date:  1985       Impact factor: 7.624

10.  Dynamic expression of cell wall proteins of Candida albicans revealed by probes from cDNA clones.

Authors:  H M Alloush; J L López-Ribot; W L Chaffin
Journal:  J Med Vet Mycol       Date:  1996 Mar-Apr
View more
  3 in total

1.  Identification of continuous B-cell epitopes on the protein moiety of the 58-kiloDalton cell wall mannoprotein of Candida albicans belonging to a family of immunodominant fungal antigens.

Authors:  A Viudes; S Perea; J L Lopez-Ribot
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Identification of major glucan-associated cell wall proteins of Candida albicans and their role in fluconazole resistance.

Authors:  Letizia Angiolella; Mia M Micocci; Simona D'Alessio; Antonietta Girolamo; Bruno Maras; Antonio Cassone
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  A proteomic analysis of secretory proteins of a pre-vacuolar mutant of Candida albicans.

Authors:  Derek P Thomas; Jose Luis Lopez-Ribot; Samuel A Lee
Journal:  J Proteomics       Date:  2009-10-09       Impact factor: 4.044

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.